CPT® Code 15360

Deleted

Tissue cultured allogeneic dermal substitute, trunk, arms, legs; first 100 sq cm or less, or 1% of body area of infants and children

A tissue cultured allogeneic dermal substitute is a specialized medical product used in the treatment of wounds or skin defects on the trunk, arms, or legs. This substitute is derived from human fibroblast cells, which are essential components of the skin that help in the formation of connective tissue. The fibroblasts are typically sourced from newborn foreskin tissue, ensuring a high level of viability and functionality. These cells are cultured and multiplied in a laboratory setting, where they are seeded onto a bioabsorbable mesh scaffold. This scaffold serves as a temporary structure that supports the fibroblasts as they grow and proliferate. As the fibroblasts multiply, they produce and secrete important substances such as human dermal collagen, matrix proteins, growth factors, and cytokines. These substances play a crucial role in wound healing and tissue regeneration by regulating the immune response and promoting the repair of damaged skin. The application of the dermal substitute involves careful preparation of the wound bed, followed by the placement of the substitute, which is then secured using sutures or staples to ensure it remains in position. After the dermal substitute is applied, a layered dressing is utilized to protect the area. This dressing typically consists of a nonadherent layer to prevent sticking to the wound, a bulky layer of gauze to absorb any exudate, a compression layer to support the area, and an anti-shear layer to minimize friction. The CPT® Code 15360 is specifically designated for the use of this dermal substitute when covering the first 100 square centimeters or less of skin area in adults, or up to 1% of the total body surface area in infants and children. For cases requiring additional coverage, CPT® Code 15361 is used for each subsequent 100 square centimeters or 1% of total body surface area.